Beaugrand, Michel

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Karlas, T., Petroff, D., Sasso, M., Fan, J.-G., Mi, Y.-Q., de Lédinghen, V., Kumar, M., Lupsor-Platon, M., Han, K.-H., Cardoso, A. C., et al. (2017) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentUltrasound Imaging and Elastography

Cited by 1,275

Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC

Corpechot, C., El Naggar, A., Poujol-Robert, A., Ziol, M., Wendum, D., Chazouillères, O., de Lédinghen, V., Dhumeaux, D., Marcellin, P., Beaugrand, M., et al. (2006) · Hepatology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 441

Telomerase gene mutations are associated with cirrhosis formation

Hartmann, D., Srivastava, U., Thaler, M., Kleinhans, K. N., N'Kontchou, G., Scheffold, A., Bauer, K., Kratzer, R. F., Kloos, N., Katz, S.-F., et al. (2011) · Hepatology

Telomeres, Telomerase, and SenescenceLiver physiology and pathology

Cited by 173

Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis

Nkontchou, G., Aout, M., Mahmoudi, A., Roulot, D., Bourcier, V., Grando-Lemaire, V., Ganne-Carrie, N., Trinchet, J.-C., Vicaut, E., & Beaugrand, M. (2012) · Cancer Prevention Research

Hepatocellular Carcinoma Treatment and PrognosisHepatitis C virus research

Cited by 79